Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Growth · Victory Capital

Victory RS Select Growth Fund Class C (RSGFX)

Ticker RSGFX · · Holdings as of Jun 30, 2026

Expense ratio
2.18%$218/yr per $10k
5-yr return
+1.8%annualized
1-yr return
+5.7%as of Dec 2025
Net assets
$91.2Mall share classes
Holdings
66

Bottom line

Is RSGFX a good fund? The bottom line

RSGFX is the Class C share class of Victory RS Select Growth Fund, an actively managed large growth mutual fund from Victory Capital.

It charges 2.18% — about $218 a year on every $10,000 invested, more expensive than 98% of large growth funds we track.

It returned +5.7% over one year, +1.8% a year over five years, +8.1% a year over ten (as of Dec 31, 2025, per its prospectus).

With $91.2 million in net assets and 66 holdings, its largest position is Guardant Health, Inc. (3.7%) and the top 10 make up 27.5% of the portfolio.

What stands out

  • No front-end sales load

What to watch

  • Expensive for its category (2.18%)
  • 5-year return in the bottom quarter of its category
  • 12b-1 marketing fee of 1% a year

Updated Nov 19, 2026

What RSGFX invests in

The Victory RS Select Growth Fund (the Fund) seeks to provide long-term capital growth.

The Adviser pursues the Funds investment objective by investing, under normal circumstances, in a portfolio of small- and mid-capitalization growth-oriented companies. The Fund typically invests in equity securities of U.S. companies but may also invest any portion of its assets in foreign securities, including depositary receipts such as American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs). The Fund principally invests in equity securities of companies with market capitalizations (at the time of purchase) less than $8 billion or 120% of the market capitalization of the largest company included in the Russell 2500 Index (the Index) (currently, approximately $112.5 billion, based on the size of the largest company in the Index on March 31, 2026), whichever is greater. The size of companies in the Index changes with market conditions and the composition of the Index.…

From the fund's prospectus (filed Jun 17, 2026).

RSGFX performance

Average annual total returns
1 yr5 yr10 yr
RSGFX+5.7%+1.8%+8.1%
Large Growth median+15.2%+11.0%+14.2%

Source: Fund prospectus, as of Dec 31, 2025

Full RSGFX performance history →

What RSGFX costs

On a $10,000 investment, RSGFX's 2.18% expense ratio costs about $218 a year. The prospectus estimates $3,741 in total costs over 10 years (assuming 5% annual returns). The median large growth fund charges 0.87%.

See the full RSGFX fee table →

RSGFX top 10 holdings

#Holding% of fund
1Guardant Health, Inc.3.66%
2Macom Technology Solutions Holdings, Inc.3.47%
3Woodward, Inc.3.01%
4Mercury Systems, Inc.2.92%
5Comfort Systems USA, Inc.2.52%
6Revolution Medicines, Inc.2.51%
7Firstcash Holdings, Inc.2.48%
8Sterling Infrastructure, Inc.2.35%
9Onto Innovation Inc.2.33%
10Semtech Corporation2.29%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 27.5% of the fund. See all top 25 holdings and asset mix →

Alternatives to RSGFX

More funds like RSGFX →

RSGFX FAQ

What is the expense ratio of RSGFX?
RSGFX's expense ratio is 2.18%, which works out to about $218 a year for every $10,000 invested. The prospectus estimates total costs of $3,741 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is RSGFX a good investment?
It depends on your goals, but the data points to: no front-end sales load; expensive for its category (2.18%); 5-year return in the bottom quarter of its category; 12b-1 marketing fee of 1% a year. This is general information, not personalized advice.
What does RSGFX hold?
RSGFX's largest holdings are Guardant Health, Inc. (3.7%), Macom Technology Solutions Holdings, Inc. (3.5%), Woodward, Inc. (3.0%), Mercury Systems, Inc. (2.9%), Comfort Systems USA, Inc. (2.5%). It holds 66 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is RSGFX's 5-year return?
RSGFX returned +1.8% a year over the five years ending Dec 31, 2025, and +8.1% a year over ten years. Past performance does not guarantee future results.
Does RSGFX have a sales load?
No. RSGFX has no front-end sales charge. It may charge a deferred sales charge of up to 1% if sold early.
Who manages RSGFX?
RSGFX is offered by Victory Capital through Victory Portfolios.